3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-(4-sulfamoylphenyl)propanamide
C21H24N4O4S2 — CID 11532712
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-(4-sulfamoylphenyl)propanamide
3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-(4-sulfamoylphenyl)propanamide (PubChem CID 11532712) has the molecular formula C21H24N4O4S2 and a molecular weight of 460.58 g/mol. Its IUPAC name is 3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-(4-sulfamoylphenyl)propanamide.
Molecular Properties
| Compound Name | 3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-(4-sulfamoylphenyl)propanamide |
|---|---|
| PubChem CID | 11532712 |
| Molecular Formula | C21H24N4O4S2 |
| Molecular Weight | 460.58 g/mol |
| Exact Mass | 460.12 |
| IUPAC Name | 3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-(4-sulfamoylphenyl)propanamide |
| SMILES | COc1ccc2nc(NC(=O)C(CC3CCCC3)c3ccc(S(N)(=O)=O)cc3)sc2n1 |
| InChI | InChI=1S/C21H24N4O4S2/c1-29-18-11-10-17-20(24-18)30-21(23-17)25-19(26)16(12-13-4-2-3-5-13)14-6-8-15(9-7-14)31(22,27)28/h6-11,13,16H,2-5,12H2,1H3,(H2,22,27,28)(H,23,25,26) |
| InChIKey | MBGKLTPGMKMMBY-UHFFFAOYSA-N |
| XLogP | 3.65 |
| TPSA | 124.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 460.58 |
| LogP ≤ 5 | 3.65 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11532712 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.